Status:
RECRUITING
Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia
Lead Sponsor:
Boston Children's Hospital
Conditions:
Hereditary Spastic Paraplegia
SPG47
Eligibility:
All Genders
Up to 30 years
Brief Summary
The Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia (HSP) is focused on gathering longitudinal clinical data as well as biological samples (skin and/or blood and/or sa...
Detailed Description
The hereditary spastic paraplegias (HSP) are a group of more than 80 neurodegenerative diseases that lead to progressive neurological decline. Collectively, the HSPs present the most common cause of i...
Eligibility Criteria
Inclusion
- Onset of hereditary spastic paraplegia symptoms before the age of 18 years
- Under the age of 30 years old
- Must have a genetically confirmed variant in HSP-related genes and a relative of an individual with a confirmed diagnosis (if applicable).
Exclusion
- Not having such a diagnosis and/or not being related to such individual
Key Trial Info
Start Date :
April 27 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 26 2026
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT04712812
Start Date
April 27 2020
End Date
April 26 2026
Last Update
October 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115